Correlation Between Mineralys Therapeutics, and Aptinyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Aptinyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Aptinyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Aptinyx, you can compare the effects of market volatilities on Mineralys Therapeutics, and Aptinyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Aptinyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Aptinyx.

Diversification Opportunities for Mineralys Therapeutics, and Aptinyx

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Mineralys and Aptinyx is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Aptinyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptinyx and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Aptinyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptinyx has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Aptinyx go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Aptinyx

If you would invest  786.00  in Mineralys Therapeutics, Common on September 13, 2024 and sell it today you would earn a total of  509.00  from holding Mineralys Therapeutics, Common or generate 64.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy0.4%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Aptinyx

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.
Aptinyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aptinyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Aptinyx is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Mineralys Therapeutics, and Aptinyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and Aptinyx

The main advantage of trading using opposite Mineralys Therapeutics, and Aptinyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Aptinyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptinyx will offset losses from the drop in Aptinyx's long position.
The idea behind Mineralys Therapeutics, Common and Aptinyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency